|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows From Operating Activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Equity in earnings of unconsolidated investments | |||||
| Distributions from unconsolidated investments | |||||
| Unrealized gains on marketable equity securities | |||||
| (Gains) losses on sale of marketable securities | |||||
| Gain on acquisition of equity method investment | |||||
| Gain on sale of unconsolidated company | |||||
| Impairment (recovery) of assets | |||||
| Gain on sale of property and equipment | |||||
| Deferred income taxes | |||||
| Impairment of assets | |||||
| Stock–based compensation | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Prepaid expenses and other assets | |||||
| Operating lease obligations | |||||
| Trade accounts payable | |||||
| Accrued payroll | |||||
| Amounts due to third party payors | |||||
| Accrued risk reserves | |||||
| Provider relief funds | |||||
| Contract liabilities | |||||
| Other current liabilities | |||||
| Other noncurrent liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash Flows From Investing Activities: | |||||
| Purchases of property and equipment | |||||
| Acquisition of skilled nursing facility | |||||
| Acquisition of businesses, net of cash acquired | |||||
| White Oak Senior Living Portfolio | |||||
| Other Business Acquisitions | |||||
| Proceeds from sale of assets | |||||
| Net cash used in investing activities | |||||
| Cash Flows From Financing Activities: | |||||
| Borrowings under credit facility | |||||
| Repayments under credit facility | |||||
| Dividends paid to common stockholders | |||||
| Issuance of common shares | |||||
| Repurchase of common shares | |||||
| Noncontrolling interest contributions | |||||
| Entrance fee deposits (refunds) | |||||
| Debt issuance costs | |||||
| Principal payments under finance lease obligations | |||||
| Net cash (used in) / provided by financing activities | |||||
| Net Increase (Decrease) in Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents | |||||
| Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Beginning of Period | |||||
| Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, End of Period | |||||
| Balance Sheet Classifications: | |||||
| Cash and cash equivalents | |||||
| Restricted Cash and Cash Equivalents | |||||
| Total Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents | |||||
| Supplemental Information: | |||||
| Cash payments for interest | |||||
| Cash payments for income taxes | |||||
| Noncontrolling interest contribution of land | |||||
| Investments in unconsolidated companies | |||||
| Acquisition of equity method investment | |||||
| Purchases of marketable securities | |||||
| Sale of marketable securities | |||||
| Collections of (investments in) notes receivable | |||||
Loading...